From: JWissmille@aol.com
Date: Sun, 25 Aug 2002 16:59:40 EDT
My daughter developed many Lyme disease symptoms after being vaccinated for rubella at the age of 14. [I was told her childhood vaccination for rubella had not taken and it was important for her to be revaccinated .] At the time we were living in Fairfield, Ct.. Her symptoms did not all come at once but, the various symptoms, did start following the vaccination. The symptoms were numerous, stomach problems, vision problems, swollen painful knees, extremely easy bruising leading to her gym teacher questioning her about her homelife, a ruptured Baker's cyst, change for the worse in her school work and grades, to name a few. The specialists I took her to could never find the cause of the particular symptom exhibited at the time. I started to believe she was "faking it" and just did not want to attend class.I have since learned that my daughter does hae Lyme disease and I have also learned that.the infection may have been activated by the vaccination.
Had I known what I know now, my daughter would not have received the rubella vaccine. I understand that about 1/3 of young women vaccinated for rubella develop symptoms of chronic arthritis.
This is something I do see on a regular basis. If you have latent
Lyme disease,
that's Lyme disease unrecognized and you receive the standard immunizations,
your disease can be reactivated instead of quieted.
.....
In the rheumatological literature it is well known that if you have
active juvenile rheumatoid
arthritis, you should not receive any of the standard immunizations
DPT,
measles, flu shot because these are known to reactivate the arthritis
phase of
that disease.
The same thing happens in Lyme disease and I've seen a lot of
patients who we clearly can state that their symptoms started within
2 weeks
of receiving the measles, mumps, german measles shots, for instance,
which is
mandatory for 5 year olds in New York before they start kindergarden.
I see a number of children present with arthritis, children whose symptoms
began
within two weeks of receiving that immunization."
Summary:
In a 19 month old girl and a 16 month old girl the gullian barre
syndrome developed within a week after they received, respectively,
live
measles-rubella vaccine and live measles vaccine. The older child was
immune to rubella at the time of vaccination, but both girls
demonstrated a primary measles antibody response. Serum obtained during
the acute and convalescent stages from the younger child was tested
for
antibodies against the herpes virus, epstein barre virus, cytomeglovirus
and varicella -zoster and found to be negative. the author goes on
to
state vaccine and wild strains can in the pathological process lead
to
demyelinzation. These two cases again emphasize the need to carefully
document the neurological diseases which follow infections with live
virus vaccines.
" In 84% of multiple sclerosis patients we were able to
demonstrate intrathecal antibody production against measles, rubella or
mumps virus............"
(This quote is from the first of the following abstracts.
I find it interesting because these three viruses
are also included in one shot for vaccinations.
What are these antibodies doing in the spinal fluid and being used as a
marker for MS?
Does anyone know?
Georgia)
Heller J, Holzer G, Schimrigk K. Immunological
differentiation between neuroborreliosis and multiple sclerosis. J
Neurol. 1990 Dec;237(8):465-70.
Heller J, Holzer G, Schimrigk K. [ELISA
for specifying oligoclonal bands of isoelectric focusing of cerebrospinal
fluid in patients with neuroborreliosis and multiple sclerosis], Nervenarzt.
1990 Apr;61(4):248-9. German.
"............ Documents produced by two Department
of Health committees
responsible for reviewing the safety and efficacy of
the vaccine, the Committee on Safety of
Medicines (CSM) and the Joint Committee on Vaccination
and Immunisation,
reveal that significant numbers of members have links
with manufacturers of
the MMR jab...."
FROM THE NEWS.TELEGRAPH.CO.UK
http://www.telegraph.co.uk/news/main.jhtml?xml=%2Fnews%2F2002%2F08%2F25%2Fnm
mr25.xml
Parents unhappy with MMR safety experts' links to drug
firms
By Lorraine Fraser, Medical Correspondent
(Filed: 25/08/2002)
Concerns are growing over the links between doctors advising
the Government
on the safety of the MMR triple vaccine and the pharmaceutical
companies
that make it.
Documents produced by two Department of Health committees
responsible for
reviewing the safety and efficacy of the vaccine, the
Committee on Safety of
Medicines (CSM) and the Joint Committee on Vaccination
and Immunisation,
reveal that significant numbers of members have links
with manufacturers of
the MMR jab.
Fifteen of the 36 members of the CSM have declared personal
or non-personal
links with companies cited in a class action being brought
by parents who
believe that the measles, mumps and rubella triple vaccine
has harmed their
children.
Six committee members have personal shareholdings and/or
hold consultancy
posts with MMR manufacturer GlaxoSmithKline and nine
have a past or present
association, such as receiving research funding from
companies involved. Two
members have declared interests in both categories.
Among the 20 members of the vaccination and immunisation
committee, two have
declared consultancy work, again with Glaxo, and six
have recorded
non-personal interests relating to relevant companies.
One member has
interests in both categories.
Although there is no evidence that their opinions on MMR
have been
influenced by their links with the pharmaceutical firms,
the extent of them
has caused disquiet.
David Thrower, a parent who has campaigned for more research
into MMR, said:
"The tolerance of potential conflicts of interest in
the medical
establishment has reached an extraordinary level, both
in terms of the scale
of the interests involved and the apparent complete disinterest
of central
government in this issue.
"Yet it is particularly critical when considering the
safety of medical
products that the people making those judgments don't
have any conflict of
interest, indirect or direct.
"You have to ask yourself, do the conflicts of interest
overwhelm
the
scientific considerations of safety."
It emerged yesterday that Phillip Minor, a professor in
charge of a
department promised a government grant to conduct a study
crucial to the MMR
debate, is being paid to advise legal firms acting for
GlaxoSmithKline on
the safety of vaccines.
The director of the institute, Stephen Inglis, who is
also a member of the
vaccination and immunisation committee, where he has
declared non-personal
interests involving Glaxo, has defended the specialists.
He said that any suggestion that the work would not be
carried out
objectively was "insulting".
A spokesman for the Department of Health said a code of
practice barred
committee members from participating in any decision
on a product if they
had declared an interest in the company making it.
"Anyone who declares any sort of interest in the pharmaceutical
industry
cannot play a part in any decision relating to those
companies and has to
leave the room when the subject arises," he said.
Parents' groups are uncomfortable with the situation,
however. Richard
Miles, who coordinates Autism Research Campaign for Health,
said: "We are
very concerned to ensure that this study does not turn
out to be a
whitewash."